2012
DOI: 10.3791/4100
|View full text |Cite
|
Sign up to set email alerts
|

Modeling Colitis-Associated Cancer with Azoxymethane (AOM) and Dextran Sulfate Sodium (DSS)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
121
0
1

Year Published

2014
2014
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 128 publications
(128 citation statements)
references
References 21 publications
6
121
0
1
Order By: Relevance
“…2H). As reported (25), histologically a majority of carcinomas were observed and no metastatic lesion was evident after 10 weeks of AOM/DSS treatment (Supplementary Fig. 2B).…”
Section: Resultssupporting
confidence: 84%
“…2H). As reported (25), histologically a majority of carcinomas were observed and no metastatic lesion was evident after 10 weeks of AOM/DSS treatment (Supplementary Fig. 2B).…”
Section: Resultssupporting
confidence: 84%
“…In this study, AOM treatment was used to increase the basal level of colorectal tumorigenesis but not for direct induction of colorectal tumor formation, so that oncogenic effects of E. coli could be detected. On day 0, mice were intraperitoneally injected with AOM (10 mg/kg), according to a published protocol (13). On day 5, mice were treated with neomycin (1 g/L), vancomycin (0.5 g/L), ampicillin (1 g/L), and metronidazole (1 g/L) in drinking water to eliminate commensal flora (14) and facilitate the colonization of fed bacteria.…”
Section: Mouse Models For Colorectal Tumorigenesismentioning
confidence: 99%
“…On day 5, mice were treated with neomycin (1 g/L), vancomycin (0.5 g/L), ampicillin (1 g/L), and metronidazole (1 g/L) in drinking water to eliminate commensal flora (14) and facilitate the colonization of fed bacteria. Dextran sulfate sodium (DSS) is typically used together with AOM to induce colorectal cancer in mice (13). However, the oncogenic action of the combination of AOM and DSS are strong and may overshadow the oncogenic effects of fed bacteria.…”
Section: Mouse Models For Colorectal Tumorigenesismentioning
confidence: 99%
“…The risk to IBD patients of developing cancer is proportional to the duration and extent of inflammation, hence the development of CAC (43). In particular, colonic dysplasia in IBD and colon cancer is thought to be the result of repeated cycles of epithelial cell injury and repair (44). In this study we used the combined AOM/DSS murine model that reproduces core features of human CAC (33).…”
Section: Malmentioning
confidence: 99%